Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × Biomarkers × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 7 Neoplasms 3 Lung Neoplasms 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pleural Effusion 1 Pituitary Diseases 1 Pituitary ACTH Hypersecretion 1 Obesity 1 Myasthenia Gravis 1 Motor Activity 1 Lymphoma 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Cardiotoxicity 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Advanced Solid Tumors 1 Adenocarcinoma of Lung 1 ACTH-Secreting Pituitary Adenoma 1

Interventions

Gemcitabine 97 Cisplatin 64 Oxaliplatin 40 pembrolizumab 31 Fluorouracil 30 Capecitabine 30 durvalumab 26 lenvatinib 24 Leucovorin 24 Radiofrequency Ablation 11 Nivolumab 11 Magnetic Resonance Spectroscopy 11 Irinotecan 11 Drug Therapy 11 apatinib 10 Radiotherapy 10 Albumin-Bound Paclitaxel 10 pemigatinib 9 Taxes 9 tislelizumab 8 Specimen Handling 8 Folfox protocol 8 Floxuridine 8 Biopsy 8 Bevacizumab 8 130-nm albumin-bound paclitaxel 8 tremelimumab 7 Liver Transplantation 7 Cholangiopancreatography, Endoscopic Retrograde 7 Carboplatin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02893085 2016-12-28

ONCOBIL

CHU de Reims

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡